Clinical Trial Update: Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the safety and tolerability of ertapenem sodium for the treatment of complicated urinary tract infections; the study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Urinary Tract Infection

Drugs mentioned

• Invanz (ertapenem)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urinary Tract Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-03-01